Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370
Related Experiment Video
Updated: Jan 22, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
1Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China. chenyuebio@126.com.
Objective:
The aberrant expression of long noncoding RNAs (lncRNAs) is involved in the molecular regulation of non-small cell lung cancer (NSCLC). This study aims to investigate the biological interaction of lnc-FAM201A and its downstream factors and their impacts on the radiotherapy response of NSCLC.
Patients And Methods:
Quantitative Polymerase Chain Reaction (qPCR) was used to determine the expression of FAM201A in NSCLC tissues. The Chi-square tests explored the association between FAM201A level and the poor clinicopathological characteristics (including radioresistance) of NSCLC. Univariate and multivariate Cox proportional hazards regression analyses were used to evaluate various prognostic factors for overall survival (OS). The effect of FAM201A on OS was tested by the log-rank test. A549/SK-MES-1 cell lines transfected with short hairpin RNA (shRNA) were used to verify the promoting effects of FAM201A on radiotherapy resistance in vitro and in vivo. Cell apoptosis (analyzed by flow cytometry), cell proliferation (determined by Cell Counting Kit-8), and mice xenograft models were performed to confirm the results. The downstream targets of FAM201A were predicted by bioinformatics tools. Additionally, the Dual-luciferase reporter assay, qPCR, and Western blotting were performed to confirm their interaction.
Results:
FAM201A was significantly upregulated in tissues obtained from NSCLC patients resistant to radiotherapy. Increased FAM201A expression was strongly associated with radioresistance and inferior survival in NSCLC, as demonstrated by clinical data. The silence of FAM201A could inhibit cell proliferation and further cell apoptosis of NSCLC cells under X-ray irradiation both in vitro and in vivo. Moreover, by competitively targeting miR-370, FAM201A elevated the epidermal growth factor receptor (EGFR) and the hypoxia-inducible factor 1alpha (HIF-1α) levels. After FAM201A knockdown, EGFR and HIF-1α were repressed with enhanced radiosensitivity.
Conclusions:
The interference of FAM201A impairs its suppression of miR-370, resulting in the upregulation of EGFR and HIF-1α and enhancement of radiosensitivity in NSCLC patients. Collectively, our results indicated that this regulatory axis might serve as a potential therapeutic target to increase the sensitivity of radiotherapy in NSCLC patients.
Insights
Long noncoding RNA FAM201A promotes radioresistance in non-small cell lung cancer (NSCLC) by targeting miR-370, upregulating EGFR and HIF-1α. Silencing FAM201A enhances radiosensitivity, suggesting it as a therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant expression of long noncoding RNAs (lncRNAs) is implicated in non-small cell lung cancer (NSCLC) pathogenesis.
- Understanding the role of specific lncRNAs, like lnc-FAM201A, is crucial for deciphering NSCLC's molecular regulation.
Purpose of the Study:
- To investigate the biological interactions of lnc-FAM201A and its downstream targets.
- To determine the impact of lnc-FAM201A on the radiotherapy response in NSCLC.
- To explore lnc-FAM201A as a potential therapeutic target for enhancing NSCLC radiosensitivity.
Main Methods:
- Quantitative Polymerase Chain Reaction (qPCR) and Chi-square tests assessed FAM201A expression and its association with NSCLC characteristics.
- Univariate and multivariate Cox regression analyses evaluated prognostic factors for overall survival (OS).
- In vitro and in vivo experiments using cell lines (A549/SK-MES-1) with short hairpin RNA (shRNA) knockdown of FAM201A, alongside apoptosis assays, proliferation assays, and xenograft models, were employed.
- Bioinformatics, Dual-luciferase reporter assays, qPCR, and Western blotting identified and confirmed downstream targets.
Main Results:
- FAM201A was significantly upregulated in NSCLC tissues resistant to radiotherapy, correlating with radioresistance and poorer survival.
- FAM201A knockdown inhibited NSCLC cell proliferation and induced apoptosis under X-ray irradiation, both in vitro and in vivo.
- FAM201A competitively targeted miR-370, leading to elevated epidermal growth factor receptor (EGFR) and hypoxia-inducible factor 1alpha (HIF-1α) levels, which were repressed upon FAM201A knockdown, enhancing radiosensitivity.
Conclusions:
- FAM201A interference disrupts its suppression of miR-370, consequently upregulating EGFR and HIF-1α, thereby enhancing NSCLC radiosensitivity.
- The identified regulatory axis involving FAM201A, miR-370, EGFR, and HIF-1α represents a potential therapeutic target to improve radiotherapy efficacy in NSCLC.
More Related Videos
07:35Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
Published on: December 1, 2023
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Related Concept Videos
RNA Polymerase II Accessory Proteins
Cell Specific Gene Expression
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Stability
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Self-Evaluation: Self-Enhancement and Self-Verification